Page last updated: 2024-11-05

tranexamic acid and Cardiomyopathy, Hypertrophic

tranexamic acid has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, K2

Other Studies

1 other study available for tranexamic acid and Cardiomyopathy, Hypertrophic

ArticleYear
Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Cardiomyopathy, Hypertrophic; Colectomy; Colostomy; Embolization, Th

2008